HopeStage
Study directory

Addiction studies

Addiction involves difficulty controlling substance use or a behaviour despite its harmful effects on everyday life.

Back to overview
More filters: keywords, city, remote
713studies shown
Showing 445-456 of 713
Behavioral study icon
RecruitingNCT07464613

Social Cognition in Severe Addiction

Official study title

Social Cognition in Severe Alcohol Use Disorder: Towards a Neuroscientific Model Linking Cognitive Processes, Neurostructural Correlates, and Social Functioning

In Reims
AddictionBehavioural studyAges 18–65
Countries
France
Sponsor
CHU de Reims
Behavioral study icon
RecruitingNCT07044466

Social Functioning in Addiction

Official study title

Real-world Assessment of Social Functioning During OUD Treatment: Integrating Reports From Patients and Their Concerned Significant Others

In Charleston
AddictionBehavioural studyAges 18+
Countries
United States
Sponsor
Medical University of South Carolina
Drug study icon
RecruitingNCT05807139

Spironolactone in Addiction (SAUD)

Official study title

Spironolactone in Alcohol Use Disorder (SAUD): A Double-Blind, Placebo-Controlled, Ascending Dose, Phase 1b Study

In Baltimore
AddictionMedication studyAges 21–99
Countries
United States
Sponsor
National Institute on Drug Abuse (NIDA)
Other study type icon
RecruitingNCT06784908

Stress and Pain in People Living With HIV

Official study title

Stress-immune Mechanisms for People Living With HIV, CUD and Depression

In New Haven
Addiction, DepressionInterventional studyAges 18–68
Countries
United States
Sponsor
Yale University
Other study type icon
RecruitingNCT06891235

an Oral Fluid Testing Approach

Official study title

Oral Fluid Testing to Assess Cannabis Non-Use in Remote Clinical Trials

In Boston
AddictionObservational studyAges 18–35
Countries
United States
Sponsor
Boston Children's Hospital
Drug study icon
RecruitingNCT07520292

NTX-2001 on Alcohol Consumption in Addiction

Official study title

The Effects of NTX-2001, a Novel TAAR1 Partial Agonist, on Alcohol Consumption in Adults With Alcohol Use Disorder: A Phase 1b, Randomized, Placebo-Controlled, Proof-of-Concept Study

In New Haven
AddictionMedication studyAges 21–60
Countries
United States
Sponsor
Newleos Therapeutics, Inc.
Drug study icon
RecruitingNCT06538558

Use of Tezampanel for Addiction

Official study title

A Phase I, Single-Center, Single-Blind, Placebo-Controlled, Dose-Escalation Study to Assess the Safety, Pharmacokinetics and Efficacy of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder

In Indianapolis
AddictionMedication studyAges 18–65
Countries
United States
Sponsor
Proniras Corporation
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.